HI
ACOR

Horizon Investments’s Acorda Therapeutics ACOR Stock Holding History

Horizon Investments’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-49
Closed -$243K – 140
2014
Q4 		$243K Hold
49
– – 0.02% 74
2014
Q3 		$201K Buy
+49
New +$184K 0.02% 93

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Horizon Investments's ACOR Position: Q1 2015 in Review

Horizon Investments sold out of Acorda Therapeutics (ACOR) in Q1 2015, closing a stake of 49 shares — an estimated $243K sold.

Horizon Investments first reported a position in ACOR in Q3 2014 and held it in 2 quarters. The position peaked at $243K in Q4 2014. 190 funds tracked by Wall St. Rank hold ACOR as of Q1 2015.

  • Horizon Investments reported no remaining Acorda Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Horizon Investments sold 49 Acorda Therapeutics shares in Q1 2015, an estimated $243K.
  • Horizon Investments first reported a position in Acorda Therapeutics in Q3 2014 and held it in 2 quarters.
  • Horizon Investments's Acorda Therapeutics position peaked at $243K in Q4 2014.
  • 190 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2015.

Based on Horizon Investments's 13F filing for Q1 2015, filed 15 May 2015.